Passa al contenuto
Merck

Vai a

1090706

USP

Capecitabine

United States Pharmacopeia (USP) Reference Standard

Sinonimo/i:

5′-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine, Ro-9-1978

Autenticati per visualizzare i prezzi organizzativi e contrattuali.

Scegli un formato

Cambia visualizzazione
A voi/SKUDisponibilitàPrezzo
200 mg
Per informazioni sulla disponibilità, contatta il Servizio Clienti.
405,00 €

Informazioni su questo articolo

Formula empirica (notazione di Hill):
C15H22FN3O6
Numero CAS:
Peso molecolare:
359.35
NACRES:
NA.24
PubChem Substance ID:
UNSPSC Code:
41116107
MDL number:

405,00 €


Per informazioni sulla disponibilità, contatta il Servizio Clienti.

Richiedi un ordine in blocco
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutarti


grade

pharmaceutical primary standard

agency

USP

API family

capecitabine

manufacturer/tradename

USP

application(s)

pharmaceutical (small molecule)

format

neat

SMILES string

O[C@H]1[C@@H](O)[C@H](N2C(N=C(NC(OCCCCC)=O)C(F)=C2)=O)O[C@@H]1C

InChI

1S/C15H22FN3O6/c1-3-4-5-6-24-15(23)18-12-9(16)7-19(14(22)17-12)13-11(21)10(20)8(2)25-13/h7-8,10-11,13,20-21H,3-6H2,1-2H3,(H,17,18,22,23)/t8-,10-,11-,13-/m1/s1

InChI key

GAGWJHPBXLXJQN-UORFTKCHSA-N

Gene Information

human ... TYMS(7298)

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Capecitabine USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:
  • Capecitabine Tablets

Biochem/physiol Actions

Capecitabine is an anti-cancer drug, a prodrug of doxifluridine, metabolized to 5-fluorouracil at the tumor site.
Capecitabine is an anti-cancer drug, a prodrug of doxifluridine, metabolized to 5-fluorouracil at the tumor site. The activation of capecitabine follows a pathway with three enzymatic steps and two intermediary metabolites, 5′-Deoxy-5-fluorocytidine (5′-DFCR) and 5′-Deoxy-5-fluorouridine (5′-DFUR), to form 5-fluorouracil.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

Confronta articoli simili

Visualizza il confronto per intero

Mostra le differenze

1 of 1

Questo articolo
Y0001642BP1229SML0653
Capecitabine United States Pharmacopeia (USP) Reference Standard

USP

1090706

Capecitabine

Capecitabine European Pharmacopoeia (EP) Reference Standard

Y0001642

Capecitabine

Capecitabine British Pharmacopoeia (BP) Reference Standard

BP1229

Capecitabine

Capecitabine ≥98% (HPLC)

Sigma-Aldrich

SML0653

Capecitabine

manufacturer/tradename

USP

manufacturer/tradename

EDQM

manufacturer/tradename

BP

manufacturer/tradename

-

grade

pharmaceutical primary standard

grade

pharmaceutical primary standard

grade

pharmaceutical primary standard

grade

-

format

neat

format

neat

format

neat

format

-

application(s)

pharmaceutical (small molecule)

application(s)

pharmaceutical (small molecule)

application(s)

pharmaceutical
pharmaceutical small molecule

application(s)

-

Gene Information

human ... TYMS(7298)

Gene Information

human ... TYMS(7298)

Gene Information

human ... TYMS(7298)

Gene Information

human ... TYMS(7298)

API family

capecitabine

API family

capecitabine

API family

capecitabine

API family

-


Still not finding the right product?

Explore all of our products under Capecitabine


pictograms

Health hazard

signalword

Danger

Hazard Classifications

Carc. 1B - Muta. 2 - Repr. 1B

Classe di stoccaggio

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documenti section.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti



Domande

Recensioni

Nessuna valutazione

Filtri attivi